A NOVEL DNA METHYLATION-BASED SURROGATE BIOMARKER FOR LATENT SYSTEMIC INFLAMMATION

Helen Meier, Eric Klopack, Mateo Farina, Belinda Hernández, Colter Mitchell, Jessica Faul, Cathal McCrory, Eileen Crimmins · 2024

Read A NOVEL DNA METHYLATION-BASED SURROGATE BIOMARKER FOR LATENT SYSTEMIC INFLAMMATION by Helen Meier, Eric Klopack, Mateo Farina, Belinda Hernández, Colter Mitchell, Jessica Faul, Cathal McCrory, Eileen Crimmins (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11692862.txt.

Description

Helen Meier and seven co-authors published a study in 2024 on a DNA-based stand-in for long-term inflammation in the body. Chronic low-grade inflammation predicts disease and death, but blood chemistry is not always available in large population studies. Chemical marks on DNA can serve as a record that survives in stored samples.

The team built their surrogate from a hidden factor drawn from seven inflammation markers. The new score tracked each marker well in a national study of older Americans. It also predicted disability, multiple illnesses, and four-year death rates about as well as the blood-based factor itself. Studies with only DNA samples can now study inflammation's role in aging with more confidence.

Catalog record

CREATORHelen Meier, Eric Klopack, Mateo Farina, Belinda Hernández, Colter Mitchell, Jessica Faul, Cathal McCrory, Eileen Crimmins
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE1 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11692862

Browse the full library · About the Tower of Babel